Barry Haarde was a cyclist and community activist whose strength will never be forgotten.
The goal of the workshop is to solicit hemophilia community-wide input into a coordinated national blueprint for future basic, translational, and clinical research.
Investigators at one HTC reported positive clinical outcomes for hemophilia patients who switched from a standard half-life to an extended half-life therapy.
Steven Pipe, MD, NHF's Chair of MASAC, looks at the future of bleeding disorders treatment.
The medication is indicated for on-demand treatment and control of bleeding episodes.
This webinar is free and open to public health professionals, clinicians, and researchers who want more information about hemophilia.
NIH will recognize Rare Disease Day with speakers, panel discussions and more on March 1, 2018.
Plan for the unexpected with these emergency preparendness resources.
This webinar aims to improve the overall knowledge of physicians in evaluating and screening women and girls with heavy menstrual bleeding for a bleeding disorder.
Update: Shire has issued a new statement regarding the injunction.
In the past few weeks, we have received many inquiries regarding the scope of the injunction Shire is seeking in its lawsuit against Genentech/Roche.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car